RepliCel Historical Income Statement
RP Stock | CAD 0.01 0.01 33.33% |
Historical analysis of RepliCel Life income statement accounts such as Total Other Income Expense Net of 1.1 M, Selling General Administrative of 1.5 M, Selling And Marketing Expenses of 472 K or Gross Profit of 374.9 K can show how well RepliCel Life Sciences performed in making a profits. Evaluating RepliCel Life income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of RepliCel Life's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining RepliCel Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether RepliCel Life Sciences is a good buy for the upcoming year.
RepliCel |
About RepliCel Income Statement Analysis
RepliCel Life Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to RepliCel Life shareholders. The income statement also shows RepliCel investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
RepliCel Life Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of RepliCel Life Sciences. It is also known as RepliCel Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in RepliCel Life Sciences financial statement analysis. It represents the amount of money remaining after all of RepliCel Life Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Most accounts from RepliCel Life's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into RepliCel Life Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, RepliCel Life's Interest Expense is fairly stable compared to the past year. Other Operating Expenses is likely to climb to about 2.7 M in 2024, whereas Operating Income is likely to drop (1.5 M) in 2024.
RepliCel Life income statement Correlations
Click cells to compare fundamentals
RepliCel Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
RepliCel Life income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 2.2K | 1.6K | 1.1K | 839.0 | 1.5K | 1.4K | |
Interest Expense | 141.4K | 176.1K | 5.5K | 6.7K | 149.1K | 156.6K | |
Other Operating Expenses | 3.3M | 1.7M | 2.7M | 1.7M | 1.7M | 2.7M | |
Operating Income | (2.9M) | (1.1M) | (3.2M) | (191.4K) | (1.4M) | (1.5M) | |
Ebit | (2.9M) | (1.1M) | (3.2M) | (191.4K) | (1.4M) | (1.5M) | |
Ebitda | (2.9M) | (1.1M) | (3.2M) | (190.6K) | (1.4M) | (1.5M) | |
Total Operating Expenses | 3.3M | 1.7M | 2.7M | 1.7M | 1.7M | 2.6M | |
Income Before Tax | (3.0M) | (1.6M) | (4.1M) | (743.2K) | (311.7K) | (327.3K) | |
Total Other Income Expense Net | (77.3K) | (252.4K) | (1.8M) | 656.1K | 1.1M | 1.1M | |
Net Income | (3.0M) | (1.6M) | (4.1M) | (743.2K) | (311.7K) | (327.3K) | |
Income Tax Expense | 44.0K | 183.5K | (867.9K) | 1.2M | (1.0) | (1.05) | |
Selling General Administrative | 1.1M | 884.7K | 1.5M | 1.1M | 1.2M | 1.5M | |
Research Development | 2.2M | 819.4K | 1.1M | 624.0K | 526.4K | 500.1K | |
Net Income From Continuing Ops | (3.0M) | (1.6M) | (4.1M) | (743.2K) | (69.3K) | (72.8K) | |
Net Income Applicable To Common Shares | (2.8M) | (3.0M) | (1.6M) | (4.1M) | (4.7M) | (4.9M) | |
Net Interest Income | (92.0K) | (175.7K) | 69.0 | (6.7K) | (1.1K) | (1.1K) | |
Interest Income | 92.0K | 358.0 | 69.0 | 43.0 | 725.0 | 688.75 | |
Reconciled Depreciation | 2.2K | 1.6K | 1.1K | 839.0 | 1.4K | 1.6K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RepliCel Stock Analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.